ebA*(TM) Multivitamin Supplement, 180 tablets in plastic bottles, Distributed by Saratoga Therapeutics, LLC, North Wales, PA.

Recall Insight

This FDA Food action (record #F-1876-2013) was formally reported on September 11, 2013, with the manufacturer initiating the action on February 13, 2013. It is classified under Critical severity (Class I), with a current status of Terminated. Saratoga Therapeutics, LLC is listed as the recalling firm, operating out of North Wales, PA. Federal records indicate 890 bottles units are affected.

The documented reason for this recall is: The recall was initiated due to discovery of the presence of milk components (milk protein(s) and lactose) despite labeling that incorrectly states it is free of milk components. Distribution data in the federal record shows the product reached: Product was sold through physicians offices and via internet sales to consumers located nationwide and in Canada.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

To put this record in context, PlainRecalls indexes 83,949 recalls across the FDA, CPSC, NHTSA and USDA FSIS going back to 1995. Within the same product category, the database holds 6 closely related recalls. That clustering is a signal — repeated actions in a narrow category often indicate a systemic quality-control issue, a supplier-wide contamination, or a design defect that has propagated across product lines. This recall is roughly 13 years old; older recalls can remain relevant because many units enter resale, rental, and secondary-market channels where the original warning never reaches the end user. Always cross-check the recall number against the official agency page before relying on any summary.